Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
Dermatol Online J
; 19(9): 19620, 2013 Sep 14.
Article
in En
| MEDLINE
| ID: mdl-24050294
ABSTRACT
Syringocystadenocarcinoma papilliferum (SCACP) is a rare adenexal carcinoma with only 21 cases reported in the literature. Most patients describe a long-standing mass with recent change, supporting the idea that SCACP arises from malignant transformation of pre-existing syringocystadenoma papilliferum (SCAP). Syringocystadenocarcinoma papilliferum is generally treated with wide surgical excision of the lesion and patients do exceeding well and require no systemic therapy.
Search on Google
Database:
MEDLINE
Main subject:
Scalp
/
Sweat Gland Neoplasms
/
Cystadenocarcinoma
/
Head and Neck Neoplasms
Type of study:
Prognostic_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Year:
2013
Type:
Article